223 related articles for article (PubMed ID: 31830113)
1. Prediction of overt hepatic encephalopathy by the continuous reaction time method and the portosystemic encephalopathy syndrome test in clinically mentally unimpaired patients with cirrhosis.
Wernberg CW; Schaffalitzky de Muckadell OB; Vilstrup H; M Lauridsen M
PLoS One; 2019; 14(12):e0226283. PubMed ID: 31830113
[TBL] [Abstract][Full Text] [Related]
2. Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests.
Lauridsen MM; Schaffalitzky de Muckadell OB; Vilstrup H
Metab Brain Dis; 2015 Oct; 30(5):1187-92. PubMed ID: 26016624
[TBL] [Abstract][Full Text] [Related]
3. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
4. The influence of HE history, HE status and neuropsychological test type on learning ability in patients with cirrhosis.
Zarantonello L; Turco M; Formentin C; Izquierdo-Altarejos P; Vuerich A; Barcenas Jimenez MJ; Montoliu C; Felipo V; Angeli P; Amodio P; Montagnese S
Liver Int; 2019 May; 39(5):861-870. PubMed ID: 30658006
[TBL] [Abstract][Full Text] [Related]
5. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
6. Effects of common chronic medical conditions on psychometric tests used to diagnose minimal hepatic encephalopathy.
Lauridsen MM; Poulsen L; Rasmussen CK; Høgild M; Nielsen MK; de Muckadell OB; Vilstrup H
Metab Brain Dis; 2016 Apr; 31(2):267-72. PubMed ID: 26435407
[TBL] [Abstract][Full Text] [Related]
7. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
[TBL] [Abstract][Full Text] [Related]
9. The continuous reaction time test for minimal hepatic encephalopathy validated by a randomized controlled multi-modal intervention-A pilot study.
Lauridsen MM; Mikkelsen S; Svensson T; Holm J; Klüver C; Gram J; Vilstrup H; Schaffalitzky de Muckadell OB
PLoS One; 2017; 12(10):e0185412. PubMed ID: 29020023
[TBL] [Abstract][Full Text] [Related]
10. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
[TBL] [Abstract][Full Text] [Related]
11. Early-Recurrent Overt Hepatic Encephalopathy Is Associated with Reduced Survival in Cirrhotic Patients after Transjugular Intrahepatic Portosystemic Shunt Creation.
Zuo L; Lv Y; Wang Q; Yin Z; Wang Z; He C; Guo W; Niu J; Bai W; Li K; Yu T; Yuan X; Chen H; Liu H; Xia D; Wang E; Luo B; Li X; Yuan J; Han N; Nie Y; Fan D; Han G
J Vasc Interv Radiol; 2019 Feb; 30(2):148-153.e2. PubMed ID: 30638778
[TBL] [Abstract][Full Text] [Related]
12. Overt hepatic encephalopathy impairs learning on the EncephalApp stroop which is reversible after liver transplantation.
Acharya C; Wade JB; Fagan A; White M; Gavis E; Ganapathy D; Gilles H; Heuman DM; Bajaj JS
Liver Transpl; 2017 Nov; 23(11):1396-1403. PubMed ID: 28885772
[TBL] [Abstract][Full Text] [Related]
13. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
[TBL] [Abstract][Full Text] [Related]
14. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
Bajaj JS; Schubert CM; Heuman DM; Wade JB; Gibson DP; Topaz A; Saeian K; Hafeezullah M; Bell DE; Sterling RK; Stravitz RT; Luketic V; White MB; Sanyal AJ
Gastroenterology; 2010 Jun; 138(7):2332-40. PubMed ID: 20178797
[TBL] [Abstract][Full Text] [Related]
15. Minimal hepatic encephalopathy is associated with a higher risk of overt hepatic encephalopathy and poorer survival.
Gairing SJ; Mangini C; Zarantonello L; Gioia S; Nielsen EJ; Danneberg S; Lok AS; Sultanik P; Galle PR; Labenz J; Thabut D; Marquardt JU; Bloom PP; Lauridsen MM; Montagnese S; Nardelli S; Labenz C
J Intern Med; 2024 Mar; 295(3):331-345. PubMed ID: 37983845
[TBL] [Abstract][Full Text] [Related]
16. Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy.
Bajaj JS; Heuman DM; Sterling RK; Sanyal AJ; Siddiqui M; Matherly S; Luketic V; Stravitz RT; Fuchs M; Thacker LR; Gilles H; White MB; Unser A; Hovermale J; Gavis E; Noble NA; Wade JB
Clin Gastroenterol Hepatol; 2015 Oct; 13(10):1828-1835.e1. PubMed ID: 24846278
[TBL] [Abstract][Full Text] [Related]
17. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
[TBL] [Abstract][Full Text] [Related]
18. Critical flicker frequency test predicts overt hepatic encephalopathy and survival in patients with liver cirrhosis.
Barone M; Shahini E; Iannone A; Viggiani MT; Corvace V; Principi M; Di Leo A
Dig Liver Dis; 2018 May; 50(5):496-500. PubMed ID: 29530628
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of covert hepatic encephalopathy: a multi-center study testing the utility of single versus combined testing.
Duarte-Rojo A; Allampati S; Thacker LR; Flud CR; Patidar KR; White MB; Klair JS; Heuman DM; Wade JB; Gavis EA; Bajaj JS
Metab Brain Dis; 2019 Feb; 34(1):289-295. PubMed ID: 30506333
[TBL] [Abstract][Full Text] [Related]
20. A shortened Stroop test to identify covert hepatic encephalopathy and predict overt hepatic encephalopathy in patients with cirrhosis.
Hanai T; Nishimura K; Miwa T; Maeda T; Nakahata Y; Imai K; Suetsugu A; Takai K; Shimizu M
J Gastroenterol; 2022 Dec; 57(12):981-989. PubMed ID: 36173512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
